Matt Luminais

Matt Luminais has a diverse work experience in the healthcare and biotechnology industries. Matt currently holds the position of Head of New Ventures at Foresite Labs since March 2022, where they previously served as the Director of New Ventures from August 2021 to March 2022. Prior to joining Foresite Labs, Matt worked as a Principal at the same company from October 2019 to July 2021.

In addition, Matt has also held key roles in other organizations. Matt served as the Interim Head of Operations at TenSixteen Bio from an unspecified date in 2021 to May 2022. Matt was also a Co-Founder at Interline Therapeutics from January 2020 to May 2021.

Before their tenure at Foresite Capital, Matt worked as an Analyst at Militia Hill Ventures from January 2018 to May 2019, preceded by an internship at the same company from June 2017 to December 2017. Matt gained research experience as a Graduate Student Researcher in Biotechnology and Biomaterials at Brown University from May 2016 to May 2017.

Additionally, Matt has held positions as a Clinical Intern at Penumbra, Inc. from June 2015 to September 2015, and as a Translational Neuroscience Research Assistant at the University of Pennsylvania from June 2014 to September 2014.

Matt Luminais has a degree in Neuroscience Sc.B from Brown University. Matt has also obtained a Master of Science (M.Sc.) degree in Biotechnology from the same institution. It is unclear when exactly they completed these degrees as the start and end years are not provided.